Form 4 for VNDA Vanda Pharmaceuticals Inc.
Accepted 2022-12-07 00:00:00 ET · period of report 2022-12-06 · accession 0001209191-22-060225 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-07 | 2022-12-06 | VNDA | Moran Kevin Patrick | SVP, CFO, Treas | M - OptEx | $3.12 | +7,500 | 125.0K | +6% | +$23.4K |
| D | 2022-12-07 | 2022-12-06 | VNDA | Moran Kevin Patrick | SVP, CFO, Treas | S - Sale+OE | $10.61 | -4,792 | 120.2K | -4% | -$50.8K |
| D | 2022-12-07 | 2022-12-06 | VNDA | Moran Kevin Patrick | SVP, CFO, Treas | M - OptEx | $0.00 | -7,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-06 | M | A | 7,500 | $3.12 | 124,952 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-06 | S | D | 4,792 | $10.61 | 120,160 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.60 to $10.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-12-06 | M | D | 7,500 | $0.00 | 0 | D | $3.12 · — to 2022-12-06 | 7,500 Common Stock | (F3) This option fully vested and exercisable. |